AVITA Medical (RCEL) Net Margin (2018 - 2025)

AVITA Medical (RCEL) posted Net Margin of 1.53% for Q4 2025, up 98.04% on a QoQ basis from 78.04% in Q3 2025, and up 6261.0% year-over-year from 0.02% in Q4 2024.

AVITA Medical (RCEL) Net Margin (2018 - 2025) Analysis & Trends

AVITA Medical's Net Margin history runs 8 years deep, the most recent figure standing at 1.53% for Q4 2025.

  • Quarterly Net Margin rose 6261.0% year-over-year to 1.53% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 26.38% (up 7039.0% YoY) and the FY2025 annual result came in at 53.59%, up 4319.0% from the prior year.
  • Net Margin was 1.53% for Q4 2025 at AVITA Medical, up from 78.04% in the prior quarter.
  • Across five years, Net Margin topped out at 226.45% in Q4 2022 and bottomed at 168.03% in Q1 2024.
  • A 5-year average of 59.13% and a median of 66.28% in 2021 frame the typical range for Net Margin.
  • Annual changes were most pronounced in 2021 — Net Margin jumped 31972 bps — and 2023, when it sank 27622 bps.
  • AVITA Medical's Net Margin stood at 63.87% in 2021, then surged by 455 bps to 226.45% in 2022, then slumped by 122 bps to 49.77% in 2023, then retreated by 29 bps to 64.14% in 2024, then jumped by 98 bps to 1.53% in 2025.
  • Business Quant data shows RCEL's Net Margin at 1.53% in Q4 2025, 78.04% in Q3 2025, and 54.43% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 9.65%
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 12.38%
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 12.84%
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 25.77%
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 16.74%
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 3.87%
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 8.01%
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 AVITA Medical 140.94 Mn 124.59 Mn 14.31 Mn -1.53%

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.53%
Sep 30, 2025 -78.04%
Jun 30, 2025 -54.43%
Mar 31, 2025 -75.63%
Dec 31, 2024 -64.14%
Sep 30, 2024 -82.91%
Jun 30, 2024 -101.30%
Mar 31, 2024 -168.03%
Dec 31, 2023 -49.77%
Sep 30, 2023 -63.85%
Jun 30, 2023 -88.35%
Mar 31, 2023 -87.39%
Dec 31, 2022 226.45%
Sep 30, 2022 -61.46%
Mar 31, 2022 -125.52%
Sep 30, 2021 -63.87%
Jun 30, 2021 -56.19%
Mar 31, 2021 -68.42%
Dec 31, 2020 -110.54%
Sep 30, 2020 -202.11%